ArticleInnovation (Cambridge (Mass.))2026
Advanced Bayesian kernel machine regression for large-scale exposome studies: Making the impossible possible.
Article in Innovation (Cambridge (Mass.)), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exposome studies involve analyzing numerous exposures with complex interactions and potential collinearity, presenting challenges for conventional statistical methods. While Bayesian kernel machine regression (BKMR) has emerged as a promising solution, its widespread adoption has been hindered by high computational costs and restricted interpretability. To address these critical limitations in large-scale exposome studies, we developed an advanced BKMR (A-BKMR) model. The Gaussian predictive process and matrix decomposition were used to reduce both processing time and memory requirements. Additionally, we employed the parametric g-formula to generate interpretable statistics, including joint and univariate effects as well as bivariate and multivariate interactions. Across various scenarios with different sample sizes and numbers of exposures, A-BKMR demonstrated both high computational efficiency and model performance. Previously, analyzing datasets with sample sizes of 100,000 was unfeasible for traditional BKMR. The current A-BKMR can complete such analyses in 1 h on a personal computer, making it over 700,000 times faster than conventional BKMR implementations. Additionally, A-BKMR can accurately identify important exposure while preserving an area under the curve (AUC) > 0.99 and an
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.